Comparative analysis between the use of MTA and Biodentine in ulpal pathologies

Abstract

Introduction: The detection and classification of pulp pathologies is fundamental since this will indicate the treatment to follow and for which we must direct it, which is why with the passing of time the need to find new materials that provide a greater biocompatibility and in turn interact as successfully as possible with the dental structure. Objective: compare the use of MTA and Biodentine in pulpal pathologies. Method: a bibliographic search of publications and systematic reviews of the literature was carried out during the months of November and December of the year 2022, in various search engines such as: Pubmed, Elsevier, Scielo, LILACS, Redalyc, Dialnet and institutional repositories, with the descriptors: “MTA and Biodentine in Pulp Pathologies”. A total of 80 sources in the aforementioned databases were reviewed, of which 19 citations in English, Portuguese and Spanish were used, selected for the review based on the selection criteria. Development: it was found that the formation of the dentinal bridge induced by Biodentine presented well-defined characteristics at the damage site. Similarly, regarding the quality of the dentin formed, there were clearly visible dentinal tubules. Biodentine presents bioactive properties, promotes the regeneration of qualified tissue, and does not show signs of pulpal inflammation. Conclusions: Bioceramics present greater characteristics of biocompatibility, ability to stimulate mineralization, antimicrobial power, and others that make it more successful in endodontic therapy than its predecessor, calcium hydroxide.